Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan;39(1):13-18.
doi: 10.1007/s11606-023-08300-6. Epub 2023 Jul 10.

Reducing Overuse of 3-Day Repeat Type and Screen Testing across an 11-Hospital Safety Net System

Affiliations

Reducing Overuse of 3-Day Repeat Type and Screen Testing across an 11-Hospital Safety Net System

Dawi Shin et al. J Gen Intern Med. 2024 Jan.

Abstract

Background: According to the American Association of Blood Banks, a Type and Screen (T&S) is valid for up to three calendar days. Beyond a limited number of clinical indications such as a transfusion reaction, repeat T&S testing within 3 days is not warranted. Inappropriate repeat T&S testing is a costly medical waste and can lead to patient harm.

Objective: To reduce inappropriate duplicate T&S testing across a large, multihospital setting.

Setting: The largest urban safety net health system in the USA, with 11 acute care hospitals.

Interventions: Our first intervention involved adding the time elapsed since the last T&S order into the order and the process instructions that described when a T&S was indicated. The second intervention was a best practice advisory that triggered when T&S was ordered before the expiration of an active T&S.

Main measures: The primary outcome measure was the number of duplicate inpatient T&S per 1000 patient days.

Key results: Across all hospitals, the weekly average rate of duplicate T&S ordering decreased from 8.42 to 7.37 per 1000 patient days (12.5% reduction, p < 0.001) after the first intervention and to 4.32 per 1000 patient days (48.7% reduction, p < 0.001) after the second intervention. Using linear regression to compare pre-intervention to post-intervention 1, the level difference was - 2.46 (9.17 to 6.70, p < 0.001) and slope difference was 0.0001 (0.0282 to 0.0283, p = 1). For post-intervention 1 to post-intervention 2, the level difference was - 3.49 (8.06 to 4.58, p < 0.001) and slope difference was - 0.0428 (0.0283 to - 0.0145, p < 0.05).

Conclusions: Our intervention successfully reduced duplicate T&S testing using a two-pronged electronic health record intervention. The success of this low effort intervention across a diverse health system provides a framework for similar interventions in various clinical settings.

Keywords: medical waste; overuse; patient safety; quality improvement; type and screen.

PubMed Disclaimer

Conflict of interest statement

No Conflicts of Interest from any of the authors.

Figures

Figure 1
Figure 1
a New process instructions with advisory statement within the Type and Screen order. b Duplicate Type and Screen Best Practice Advisory.
Figure 2
Figure 2
Interrupted time series regression comparing the weekly average rate of duplicate T&S preintervention to postintervention 1 and 2.

Similar articles

References

    1. Boral LI, Henry JB. The type and screen: a safe alternative and supplement in selected surgical procedures. Transfusion. 1977;17(2):163–168. doi: 10.1046/j.1537-2995.1977.17277151923.x. - DOI - PubMed
    1. Yazer MH. The blood bank "black box" debunked: pretransfusion testing explained. CMAJ. 2006;174(1):29-32. 10.1503/cmaj.050919. - PMC - PubMed
    1. Compton ML, Szklarski PC, Booth GS. Duplicate Type and Screen Testing: Waste in the Clinical Laboratory. Arch Pathol Lab Med. 2018;142(3):358–363. doi: 10.5858/arpa.2016-0629-OA. - DOI - PubMed
    1. Procop GW, Yerian LM, Wyllie R, Harrison AM, Kottke-Marchant K. Duplicate laboratory test reduction using a clinical decision support tool. Am J Clin Pathol. 2014;141(5):718–723. doi: 10.1309/AJCPOWHOIZBZ3FRW. - DOI - PubMed
    1. Riley JD, Stanley G, Wyllie R, Burt HL, Horwitz SB, Cooper DD, Procop GW. An Electronic Strategy for Eliminating Unnecessary Duplicate Genetic Testing. Am J Clin Pathol. 2020;153(3):328–332. doi: 10.1093/ajcp/aqz163. - DOI - PubMed

LinkOut - more resources